U.S. Banks Stock News

If you are wondering whether CleanSpark's current share price lines up with its underlying worth, this breakdown will help you connect the stock chart to valuation numbers. CleanSpark closed at US$9.40, with returns of 1.4% over the last 30 days, an 18.6% decline year to date, gains of 26.3% over 1 year, and a very large 3 year return of 249.4%, set against a 55.3% decline over 5 years. Recent coverage has focused on CleanSpark as part of broader commentary on software and tech related...

Event context and recent stock performance Norfolk Southern (NSC) has attracted fresh attention after recent share price moves, with the stock showing a 1 day return of 1.04%, a 7 day decline of 2.86%, and a month drop of 11.26%. Over the past 3 months, the stock shows a 3.54% decline, while the year to date return stands at a 2.34% decline. This performance provides a basis for a closer look at the business and valuation setup. See our latest analysis for Norfolk Southern. At a share price...

Darden Restaurants (DRI) just turned in its Q3 2026 scorecard, reporting revenue of US$3.3b and basic EPS of US$2.70. This helps investors weigh the latest quarter against its recent track record. Over the past few periods, revenue has moved from US$3.2b in Q3 2025 to US$3.3b in Q3 2026, while basic EPS went from US$2.76 to US$2.70, giving a clear sense of where the top and bottom lines currently sit. With net profit margin now at 8.7% versus 9.0% a year earlier, the story for this quarter...

Vertex Pharmaceuticals recently reported positive past interim Phase 3 RAINIER data for its investigational drug povetacicept in IgA nephropathy, with clinically meaningful proteinuria and Gd-IgA1 reductions, and advanced a rolling Biologics License Application toward potential accelerated FDA approval. The results highlight Vertex’s push beyond cystic fibrosis into kidney and autoimmune diseases, positioning povetacicept as a potentially important new biologic in a competitive renal...

On March 18, 2026, Deliverect announced a partnership with Papa John’s International to deploy its Smart Dispatch & Delivery Management platform across all U.S. restaurants by the end of 2027, integrating orders from in-house and third-party delivery into a single system. This nationwide technology upgrade could become a key test of whether more centralized, software-driven delivery operations meaningfully improve consistency and customer experience across a large pizza chain. Next, we’ll...

If you are wondering whether Powell Industries is still attractively priced after a strong run, it helps to zoom out and look at what the current share price might already be factoring in. The stock trades at US$516.00 after a 2.6% move over the last 7 days, a 5.0% decline over 30 days, with returns of 46.4% year to date and 181.2% over the past year, alongside a very large gain over 5 years. Recent coverage has focused on Powell Industries as an electrical equipment name that has attracted...

Amazon Web Services has agreed to purchase and deploy over 1 million Nvidia GPUs, plus networking and inference chips, through 2027. The multi year, billion dollar alliance is focused on upgrading AWS's AI infrastructure with Nvidia's compute and networking stack. The deal is designed to expand AWS's capacity to run AI workloads and compete with Microsoft Azure and Google Cloud. For investors watching Amazon.com (NasdaqGS:AMZN), this GPU and networking agreement sits on top of an already...

Why Getty Realty (GTY) Is On Investors’ Radar Today Getty Realty (GTY), a net lease REIT focused on single tenant retail properties, has recently drawn attention as investors reassess its month and past 3 months share performance alongside its current income and growth profile. See our latest analysis for Getty Realty. After a recent 3.5% one day share price decline, Getty Realty’s 90 day share price return of 14.53% and 1 year total shareholder return of 12.37% point to momentum that has...

If you are wondering whether Travelers Companies at around US$296.60 is still reasonably priced or starting to look stretched, you are not alone. The stock has seen mixed recent returns, with a 1.9% decline over 7 days and a 0.6% decline over 30 days, while still sitting on gains of 4.0% year to date and 17.4% over 1 year, and a very large 3 year and 5 year return profile at 90.1% and 113.1% respectively. Recent attention on insurers' underwriting discipline, catastrophe exposure and capital...

AEP Ohio, the U.S. Department of Energy and SB Energy announced a multi billion dollar investment in advanced transmission infrastructure at the former Piketon gaseous diffusion plant in Appalachian Ohio. The project is intended to power a planned 10 gigawatt data center campus and support broader economic development at the repurposed site. The partners highlighted an approach that aims to fund new transmission expansion without increasing rates for Ohio residents. American Electric Power...

Event overview and recent performance Monte Rosa Therapeutics (GLUE) has drawn fresh attention after recent trading. The stock closed at US$15.63 and recorded a 14.5% decline over the past month, alongside a small gain over the past 3 months. See our latest analysis for Monte Rosa Therapeutics. For context, the recent 14.5% one-month share price decline comes after a far stronger longer run. The 1-year total shareholder return is 169.5% and the 3-year total shareholder return is 131.9%. This...

Red Cat Holdings, Inc. has reported fourth-quarter 2025 sales of US$26.24 million, sharply higher than the prior year, while reducing its quarterly net loss to US$19.66 million and narrowing loss per share from US$0.33 to US$0.17. Alongside this record quarter, the company is rapidly scaling its Black Widow drone and maritime Blue Ops divisions, supported by new international defense interest including a request from Ukrainian forces to replace Chinese-made ISR drones and fresh orders from...

If you have been watching Taiwan Semiconductor Manufacturing and wondering whether the current share price still makes sense, this breakdown is designed to help you focus on what the numbers are actually saying about value. The stock recently closed at US$329.24, with returns of 3.0% year to date, 88.1% over 1 year, 267.3% over 3 years and 201.4% over 5 years. However, the share price has seen a 2.7% decline over the last 7 days and a 9.1% decline over the last 30 days. Recent attention on...

Ecolab (NYSE:ECL) agreed to acquire CoolIT Systems, a provider of liquid cooling technology for data centers, in a US$4.75b deal. The transaction expands Ecolab’s reach beyond its core water and hygiene services into data center cooling for AI infrastructure. The acquisition positions Ecolab to address demand for efficient thermal management solutions in next generation data centers. Ecolab is known for its water treatment, hygiene, and cleaning solutions across industries such as food,...

Eaton (NYSE:ETN) has launched Brightlayer Energy, an AI powered energy management platform for commercial and institutional buildings. The system is designed to optimize energy use across facilities and help monetize distributed energy resources such as on site generation and storage. Brightlayer Energy extends Eaton's AI capabilities beyond data centers into broader building energy management and grid connected assets. Eaton, trading at $356.8 per share, has seen a 22.3% return over the...

Earlier this week, MACOM Technology Solutions announced new 448G PAM4 modulator drivers supporting 400G-per-lane transmission for 1.6T and 3.2T optical transceivers, alongside showcasing high-speed interconnect solutions at OFC 2026. The company also joined Broadcom, Cisco, NVIDIA and Semtech in the new 400G Optical MSA, underscoring its role in shaping interoperable high-speed optical standards for AI and HPC data centers. Next, we’ll examine how MACOM’s 448G PAM4 drivers and 400G Optical...

Earlier this month, Okta, Inc. unveiled “Okta for AI Agents,” a platform and blueprint to discover, register, and govern AI agents, including previously unknown “shadow” agents, treating them as first-class, non-human identities with centralized access control, credential management, and an instant enterprise-wide kill switch. This move highlights how identity vendors are starting to position themselves as the control plane for rapidly growing autonomous AI usage, addressing emerging...

Clear Secure (YOU) is expanding further into healthcare, with Ochsner Health rolling out the CLEAR1 identity platform across patient and employee workflows, while investors also watch an upcoming transition in the company’s general counsel role. See our latest analysis for Clear Secure. That healthcare push and the upcoming general counsel change sit against a share price of US$48.12, with a 30-day share price return of 44.33% and a 1-year total shareholder return of 91.04%. This suggests...

Key context for Riot Platforms after recent price moves Riot Platforms (RIOT) has seen its share price move recently, with a 5.4% decline over the past day and softer performance over the past week, month, and past 3 months, drawing attention to its fundamentals. See our latest analysis for Riot Platforms. While the recent 13.6% 30 day share price decline and softer year to date share price return suggest fading short term momentum, the 68.3% 1 year total shareholder return points to a very...

Wondering whether Paylocity Holding at around US$112 per share still reflects its true worth, or if the market is mispricing it right now. The stock has inched up about 2.9% over the last week and month, yet it is still down 22.8% year to date and 41.4% over the past year, which can change how you think about its risk and potential. These moves sit against a backdrop of ongoing interest in software and HR technology companies. Investors continue to reassess what they are willing to pay for...

Humacyte, Inc. recently secured a binding minimum purchase commitment of US$1.475 million for its Symvess acellular tissue engineered vessel in Saudi Arabia, alongside filing a US$20 million follow-on common stock offering and submitting a Marketing Authorization Application for Symvess in Israel for arterial trauma repair. Taken together, these moves highlight Humacyte’s effort to turn its trauma-focused technology into an internationally adopted product, pairing early commercial traction...

Earnings event puts Teekay (TK) under the microscope Teekay (TK) just released full year 2025 results, with sales of US$949.52 million and net income of US$98.11 million, both below the prior year. This has put the stock back in focus for investors. See our latest analysis for Teekay. Teekay’s latest earnings release, which showed lower sales and net income than the prior year, comes after a strong run, with a 90 day share price return of 25.41% and a 1 year total shareholder return of...

Why Zevra Therapeutics Is On Investor Radar Today Zevra Therapeutics (ZVRA) has drawn investor attention after recent trading, with the share price closing at US$9.23 and posting mixed short term returns alongside stronger total returns over the past 3 years. See our latest analysis for Zevra Therapeutics. The recent 7 day share price return of 7.51% and 1 day decline of 1.81% come after a period of steadier momentum. The 30 day share price return of 3.82% and the 3 year total shareholder...

If you are wondering whether Eli Lilly's share price still makes sense after a strong multi year run, the key question now is how its current market price lines up with its underlying value. The stock closed at US$906.70, with returns of 9.1% over 1 year, very large gains over 3 years, and 414.3% over 5 years, while also seeing shorter term pullbacks of 8.0% over 7 days, 11.2% over 30 days, and 16.1% year to date. Recent headlines around Eli Lilly have focused heavily on its role in high...